Xeris Biopharma Holdings Debt-to-Assets Ratio Growth & History (XERS)

Xeris Biopharma Holdings's debt-to-assets ratio was 0.67 for fiscal 2025.

View full Xeris Biopharma Holdings company overview

Xeris Biopharma Holdings annual debt-to-assets ratio history

Xeris Biopharma Holdings annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.67−0.17−19.91%
20242024-12-310.840.13+18.27%
20232023-12-310.710.14+23.58%
20222022-12-310.570.29+98.68%
20212021-12-310.29−0.26−47.08%
20202020-12-310.55

Xeris Biopharma Holdings debt-to-assets ratio trends

Over the last five fiscal years, Xeris Biopharma Holdings's debt-to-assets ratio increased from 0.55 to 0.67, a change of 0.13. The latest reported quarter, Q2 2026, shows 0.70.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Xeris Biopharma Holdings source filings ↗

Community posts

It’s quiet here.

No posts about XERS yet. Start the conversation.

Write the first post